{
    "organizations": [],
    "uuid": "bbd6b1807eb84d1352dfc87ac508328d11de88ae",
    "author": "",
    "url": "https://www.reuters.com/article/brief-veracyte-announces-precision-medic/brief-veracyte-announces-precision-medicine-collaboration-with-loxo-oncology-idUSFWN1RO0NH",
    "ord_in_thread": 0,
    "title": "BRIEF-Veracyte Announces Precision Medicine Collaboration With Loxo Oncology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11, 2018 / 12:27 PM / Updated 14 minutes ago BRIEF-Veracyte Announces Precision Medicine Collaboration With Loxo Oncology Reuters Staff \nApril 11 (Reuters) - Veracyte Inc : \n* VERACYTE ANNOUNCES PRECISION MEDICINE COLLABORATION WITH LOXO ONCOLOGY \n* FINANCIAL AND OTHER TERMS OF AGREEMENT WERE NOT DISCLOSED. \n* LOXO ONCOLOGY WILL ACCESS VERACYTEâ€™S NEW AFIRMA XPRESSION ATLAS PLATFORM AS PER DEAL Source text for Eikon: Further company coverage:",
    "published": "2018-04-11T15:26:00.000+03:00",
    "crawled": "2018-04-11T15:49:12.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "precision",
        "medicine",
        "collaboration",
        "loxo",
        "oncology",
        "reuters",
        "staff",
        "april",
        "reuters",
        "veracyte",
        "inc",
        "veracyte",
        "announces",
        "precision",
        "medicine",
        "collaboration",
        "loxo",
        "oncology",
        "financial",
        "term",
        "agreement",
        "disclosed",
        "loxo",
        "oncology",
        "access",
        "veracyte",
        "new",
        "afirma",
        "xpression",
        "atlas",
        "platform",
        "per",
        "deal",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}